treatment of Restless Leg Syndrome associated end stage renal disease
Phase 3
- Conditions
- restless leg syndrome, chronic renal failure.Other specified extrapyramidal and movement disorders
- Registration Number
- IRCT2014011216183N1
- Lead Sponsor
- Ilam University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
patients with End Stage Renal Disease (ESRD); older than 18 years; more 12 week undergoing dialysis; patients with Restless Leg Syndrome (RLS)
Exclusion criteria: patients with iron and folate deficiency
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intensity of symptoms. Timepoint: before and 1 month after intervention. Method of measurement: Standard questionnaires.;Frequency of symptoms. Timepoint: before and 1 month after intervention. Method of measurement: Standard questionnaires.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: One month after of intervention. Method of measurement: Standard questionnaire.